Neurotrope
May 19, 2020
Moderna’s COVID-19 Vaccine; Quidel’s Lyra gets EUA from FDA; Neurotrope and Metuchen Pharma Announced Merger Agreement; FDA Approval to Rucaparib;
Moderna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273. The results of interim Phase I clinical trial showed promising outcomes in terms of efficacy and tolerability and potential of mRNA-1273 against COVID-19. The company received the funds for conductin...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
